| 1 |
Hermida RC, Ayala DE, Mojón A, Fernández JR. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level-the “normotensive nondipper” paradox [J]. Chronobiol Int,2013,30(1-2):87-98.
|
| 2 |
Soylu A, Yazici M, Duzenli MA, et al. Relation between abnormalities in circadian blood pressure rhythm and target organ damage in normotensives [J]. Circ J,2009,73(5):899-904.
|
| 3 |
Mojón A,Ayala DE,Piñeiro L,et al. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease [J]. Chronobiol Int,2013,30(1-2):145-158.
|
| 4 |
Mancia G, Fagard R, Narkiewicz K, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology(ESC): ESH/ESC task force for the management of arterial hypertension [J]. J Hypertens,2013,31(10):1925-1938.
|
| 5 |
Hermida RC, Smolensky MH, Ayala DE, et al. Abnormalities in chronic kidney disease of ambulatory blood pressure 24 h patterning and normalization by bedtime hypertension chronotherapy [J].Nephrol Dial Transplant,2013, Sep 5. [Epub ahead of print].
|
| 6 |
Iimuro S, Imai E, Watanabe T, et al. Clinical correlates of ambulatory BP monitoring among patients with CKD [J]. Clin J Am Soc Nephrol,2013,8(5):1-10.
|
| 7 |
Davidson MB,Hix JK,Vidt DG,Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate [J]. Arch Intern Med,2006,166(8):846-852.
|
| 8 |
Redon J, Plancha E, Swift PA, et al. Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4 [J]. J Hypertens,2010,28(3):602-607.
|
| 9 |
Lin L,He Y. Contributing factors for circadian rhythm variation of blood pressure in adult IgAN patients[J]. J Am Soc Nephrol,2013,24:421A.
|
| 10 |
Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes[J].N Engl J Med,2002,347(11):797-805.
|
| 11 |
Goswami P, Drawz P, Rahman M. Nocturnal dosing and chronic kidney disease progression: new insights [J]. Curr Opin Nephrol Hypertens,2009,18(5):381-385.
|
| 12 |
Tsioufis C, Andrikou I, Thomopoulos C, et al. Comparative prognostic role of nighttime blood pressure and nondipping profile on renal outcomes [J]. Am J Nephrol,2011,33(3):277-288.
|
| 13 |
Cohen DL, Huan Y, Townsend RR. Townsend. Ambulatory Blood Pressure in Chronic Kidney Disease[J]. Curr Hypertens Rep,2013,15(3):160-166.
|
| 14 |
de la Sierra A, Gorostidi M, Banegas JR, et al. Nocturnal hypertension or nondipping: which Is better associated with the cardiovascular risk profile [J]? Am J Hypertens, 2013 Sep 23.[Epub ahead of print].
|
| 15 |
Amar J,Vernier I, Rossignol E,et al. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients [J]. Kidney Int,2000,57(6):2485-2491.
|
| 16 |
Liu M, Takahashi H, Moriua Y, et al. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients [J]. Nephrol Dial Transplant,2003,18(3):563-569.
|
| 17 |
Wang C,Zhang J,Liu X,et al. Reversed dipper blood-pressure pattern is closely related to severe renal and cardiovascular damage in patients with chronic kidney disease [J]. PLoS One,2013,8(2):e55419.
|
| 18 |
Tonbul Z, Altintepe L, Sözlü C, et al. Ambulatory blood pressure monitoring in haemodialysis and continuous ambulatory peritoneal dialysis(CAPD) patients [J]. J Hum Hypertens,2002,16(8):585-589.
|
| 19 |
Kanbay M, Turgut F, Uyar ME, et al. Causes and mechanisms of nondipping hypertension [J]. Clin Exp Hypertens, 2008, 30(7):585-597.
|
| 20 |
Firsov D, Bonny O. Olivier Bonny. Circadian regulation of renal function [J]. Kidney Int,2010,78(7):640-645.
|
| 21 |
Bonny O, Firsov D. Circadian regulation of renal function and potential role in hypertension [J]. Curr Opin Nephrol Hypertens,2013,22(4):439-444.
|
| 22 |
Mahabala C, Kamath P, Bhaskaran U, et al. Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently [J]? Vasc Health Risk Manag,2013,9:125-133.
|
| 23 |
Hermida RC, Ayala DE, Mojón A, et al. Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD[J]. J Am Soc Nephrol,2011,22(12):2313-2321.
|
| 24 |
Yanagi M, Tamura K, Fujikawa T, et al. The angiotensin Ⅱtype 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease [ J].Hypertens Res,2013,36(3):262-269.
|
| 25 |
Minutolo R, Gabbai FB, Borrelli S, et al. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD:an 8-week uncontrolled trial [J]. Am J Kidney Dis,2007,50(6):908-917.
|
| 26 |
Hermida RC, Ayala DE, Smolensky MH, et al. Chronotherapy improves blood pressure control and reduces vascular risk in CKD[J]. Nat Rev Nephrol,2013,9(6):358-368.
|
| 27 |
Crespo JJ,Piñeiro L,Otero A,et al. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease [J]. Chronobiol Int,2013,30(1-2):159-175.
|